Skip to main content
. 2022 Mar 31;10(4):826. doi: 10.3390/biomedicines10040826

Figure 4.

Figure 4

Ranking plot of different treatments for facial angiofibroma based on the surface under the cumulative ranking curve (SUCRA) values for two outcomes: clinical improvement and severe adverse events leading to withdrawal. Treatments in the upper right corner were associated with greater increase in complete clearance and lesser adverse events associated withdrawal than the other treatments.